Clinical Trials Browser

Observational × Hypersensitivity × tislelizumab × Clear all

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Not yet recruiting

Hypersensitivity, Triple Negative Breast Neoplasms